Somalogic
SomaLogic Seeks 'Strategic Alternatives' for Dx Business to Focus on Life Science Market
The proteomics firm is in talks to either spin off its SomaSignal assays unit or to partner with another company to boost its diagnostics efforts.
In Brief This Week: SomaLogic, Centogene, Yourgene, Epigenomics, Biodesix, More
News items for the week of Dec. 19, 2022.
SomaLogic Scores One-Time, $21.2M Licensing Royalty in Q3, Raises FY 2022 Revenue Guidance
The Boulder, Colorado-based proteomics assay maker beat Wall Street estimates on the top and bottom lines in Q3, driven by higher product revenues.
In Brief This Week: Thermo Fisher Scientific, Leica Biosystems, Genetron, SomaLogic, More
News items for the week of Nov. 7, 2022.
SomaLogic Inks Partnership for Testing in UAE, Firm's Q2 Revenues Down 29 Percent
The firm beat the Wall Street bottom-line estimate but missed the top-line estimate and lowered its 2022 revenue guidance by approximately 20 percent.
May 13, 2022
May 12, 2022
SomaLogic Q1 Revenues Grow 22 Percent
Mar 30, 2022
Jan 6, 2022
Jun 30, 2021